1834.2.Full.Pdf
Ann Rheum Dis: first published as 10.1136/annrheumdis-2019-eular.3458 on 27 May 2019. Downloaded from 1834 Scientific Abstracts Celgene Corporation, Lichen Teng Employee of: Celgene Corporation, Genentech/Roche, GlaxoSmithKline, Janssen, LEO, Meiji, Merck Sharp & Arthur Kavanaugh Grant/research support from: UCB Pharma Dohme, Novartis, Pfizer, Purdue Pharma, Regeneron, Revance, Sandoz, DOI: 10.1136/annrheumdis-2019-eular.1860 Sanofi Genzyme, Sienna Pharmaceuticals, Sun Pharmaceuticals, UCB Pharma, Valeant, Vidac, Consultant for: AbbVie, Aclaris, Akros, Allergan, Almirall, Amgen, Boehringer Ingelheim, Celgene, Dermavant, Dermira Inc., Eli Lilly and Company, Galderma, Genentech/Roche, GlaxoSmithKline, AB0738 DUAL NEUTRALISATION OF INTERLEUKIN (IL)–17A Janssen, LEO, Meiji, Merck Sharp & Dohme, Novartis, Pfizer, Purdue AND IL–17F WITH BIMEKIZUMAB IN MODERATE-TO- Pharma, Regeneron, Revance, Sandoz, Sanofi Genzyme, Sienna Pharma- SEVERE PLAQUE PSORIASIS: 60-WEEK RESULTS ceuticals, Sun Pharmaceuticals, UCB Pharma, Valeant, Vidac., Speakers FROM A RANDOMISED, DOUBLE-BLINDED, PHASE 2B EXTENSION STUDY bureau: Janssen, Regeneron, Sanofi Genzyme, Kim A. Papp Grant/ research support from: AbbVie, Akros, Allergan, Amgen, Anacor, Arcutis, 1 2 3 4 Andrew Blauvelt , Kim A. Papp , Joseph F. Merola , Alice B. Gottlieb , Astellas, Baxalta, Boehringer Ingelheim, Bristol-Meyers Squibb, Can-Fite 5 5 5 6 Nancy Cross , Cynthia Madden ,MaggieWang , Christopher Cioffi ,Christopher Biopharma, Celgene, Coherus, Dermira, Dow Pharma, Eli Lilly, Galderma, 7 1 E.M. Griffiths
[Show full text]